Trademark Overview
On Tuesday, June 24, 2025, a trademark application was filed for SORT-LNP with the United States Patent and Trademark Office. The USPTO has given the SORT-LNP trademark a serial number of 99250011. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 24, 2025. This trademark is owned by ReCode Therapeutics, Inc. The SORT-LNP trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing information, namely, providing online, non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs
Providing medical information in the fields of genetic medicine and drug delivery
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery
